首页 | 本学科首页   官方微博 | 高级检索  
     


Safety,feasibility and effectiveness of first in‐human administration of muscle‐derived stem/progenitor cells modified with connexin‐43 gene for treatment of advanced chronic heart failure
Authors:Adrian Gwizdala  Natalia Rozwadowska  Tomasz Jan Kolanowski  Agnieszka Malcher  Aleksandra Cieplucha  Bartlomiej Perek  Wojciech Seniuk  Ewa Straburzynska‐Migaj  Zofia Oko‐Sarnowska  Witold Cholewinski  Michal Michalak  Stefan Grajek  Maciej Kurpisz
Affiliation:1. Poznan University of Medical Sciences, 1st Department of Cardiology, Poznan, Poland;2. Department of Reproductive Biology and Stem Cells, Institute of Human Genetics Polish Academy of Sciences, ul. Strzeszynska 32, Poznan, Poland;3. Poznan University of Medical Sciences, Department of Cardiac Surgery, Poznan, Poland;4. Greater Poland Cancer Centre, Nuclear Medicine Department, Poznan, Poland;5. Poznan University of Medical Sciences, Department of Statistics, Poznan, Poland
Abstract:
Keywords:Heart failure  Muscle‐derived stem cells  Connexin‐43  Transendocardial injection
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号